OUTCOMES AND COSTS OF G-CSF AND PLERIXAFOR VS CYCLOPHOSPHAMIDE (CY) AND G-CSF AS A FIRST-LINE MOBILIZING APPROACH FOR PATIENTS WITH MULTIPLE MYELOMA (MM) WHO ARE CANDIDATES FOR AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION (APSCT)